Skip to main navigation Skip to search Skip to main content

Noninvasive detection of hypoxic myocardium using fluorine-18- fluoromisonidazole and positron emission tomography

  • G. V. Martin
  • , J. H. Caldwell
  • , M. M. Graham
  • , J. R. Grierson
  • , K. Kroll
  • , M. J. Cowan
  • , T. K. Lewellen
  • , J. S. Rasey
  • , J. J. Casciari
  • , K. A. Krohn

Research output: Contribution to journal › Article › peer-review

Abstract

Fluoromisonidazole (FMISO) is metabolically trapped in viable cells as a function of reduced cellular pO2. Therefore [18F]FMISO is potentially useful for evaluating patients with hypoxic but viable myocardium. The goal of this study was to investigate [18F]FMISO uptake in ischemic myocardium noninvasively using positron emission tomography (PET). Studies were performed in 10 open-chest dogs subjected to either complete (Group 1, n = 5) or partial (Group 2, n = 5) occlusion of the left anterior descending coronary artery. The tracer was administered by intravenous bolus following the onset of ischemia and serial PET images were acquired for the next 4 hr. In Group 1, viability was assessed using histochemical staining (nitroblue tetrazolium, NBT) and 99mTc-pyrophosphate (Tc-PYP). In Group 2, viability was assessed using measurements of regional wall motion, histochemical staining and histology (two animals). In each study, PET images obtained at times between 2 and 4 hr postinjection showed specific enhancement of tracer activity in the distal anterior wall and apex of the left ventricle. At 4 hr, the tissue-to-blood pool count ratio was significantly higher in ischemic regions; 1.8 ± 0.4 for Group 1 and 1.6 ± 0.2 for Group 2 versus 1.0 ± 0.1 in nonischemic regions. Postmortem tissue sampling of Group 1 hearts showed significant FMISO retention in samples without evidence for infarction, either by NBT or Tc-PYP deposition, as well as in more severely ischemic regions. In Group 2 animals, FMISO was retained in myocardial regions with reduced blood flow (microspheres), which exhibited improved contraction following reperfusion. We conclude that PET imaging of [18F]FMISO is a promising technique for the noninvasive identification of viable hypoxic myocardium.

Original languageEnglish (US)
Pages (from-to)2202-2208
Number of pages7
JournalJournal of Nuclear Medicine
Volume33
Issue number12
StatePublished - 1992
Externally publishedYes

Funding

FundersFunder number
National Institute of Health-National Cancer InstituteP01CA042045

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging

    Fingerprint

    Dive into the research topics of 'Noninvasive detection of hypoxic myocardium using fluorine-18- fluoromisonidazole and positron emission tomography'. Together they form a unique fingerprint.

    Cite this